SCDM and ACRP Partner to Expand Services
The Society for Clinical Data Management and the Association of Clinical Research Professionals are pleased to announce a new collaboration that will help the organizations improve their support of professionals in clinical research.
“This is a natural relationship that makes sense for the members of both organizations,” said Ralph J. Russo, CCDM, chair of the SCDM Board of Trustees. “By providing events and educational opportunities across organizations, this agreement will foster innovation and synergy in the way data managers and other clinical professionals work together each day.”
Representing a combined 22,500 members worldwide, SCDM and ACRP share a common interest in promoting excellence among the various roles in clinical research. Collaborative efforts may include jointly-sponsored education programs, publication of best practices and cross-promotion of meetings and events.
“We are extremely excited to combine our efforts with SCDM,” said James D. Thomasell, CPA, ACRP executive director. “Our organizations are a natural fit both in terms of our missions and culture. We look forward to working closely with SCDM in advancing our missions and benefiting the clinical research enterprise.”
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
